Humana Inc. $HUM Stock Holdings Cut by Voya Investment Management LLC

Voya Investment Management LLC decreased its stake in Humana Inc. (NYSE:HUM – Free Report) by 9.9% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 354,828 shares of the insurance provider’s stock after selling 39,194 shares during the period. Voya Investment Management LLC’s holdings in Humana were worth $135,392,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in HUM. Johnson Financial Group Inc. acquired a new stake in shares of Humana during the 2nd quarter valued at $26,000. Trust Co. of Vermont bought a new stake in Humana during the 2nd quarter worth $28,000. Bogart Wealth LLC grew its position in Humana by 192.0% during the 2nd quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider’s stock worth $29,000 after acquiring an additional 48 shares during the last quarter. MidFirst Bank acquired a new position in Humana in the 2nd quarter worth about $35,000. Finally, Highland Investment Advisors LLC acquired a new position in Humana in the 2nd quarter worth about $43,000. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Stock Performance

NYSE HUM opened at $386.73 on Thursday. The company has a market capitalization of $46.45 billion, a price-to-earnings ratio of 37.62, a PEG ratio of 2.11 and a beta of 0.65. Humana Inc. has a twelve month low of $163.11 and a twelve month high of $462.87. The stock has a fifty day simple moving average of $410.26 and a 200 day simple moving average of $320.44. The company has a quick ratio of 1.65, a current ratio of 1.65 and a debt-to-equity ratio of 0.61.

Humana (NYSE:HUM – Get Free Report) last announced its earnings results on Friday, November 6th. The insurance provider reported ($0.70) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.00) by $0.30. The business had revenue of $41.16 billion during the quarter, compared to analyst estimates of $40.87 billion. Humana had a return on equity of 8.50% and a net margin of 0.81%. Humana’s revenue for the quarter was up 26.1% compared to the same quarter last year. During the same period last year, the company earned $3.24 EPS. Humana has set its FY 2026 guidance at 9.500- EPS. Sell-side analysts expect that Humana Inc. will post 9.66 EPS for the current year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 29th. Stockholders of record on Thursday, December 24th will be given a dividend of $0.8850 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Thursday, December 24th. Humana’s dividend payout ratio (DPR) is 34.44%.

Insider Activity at Humana

In related news, insider Joseph Ventura sold 5,495 shares of Humana stock in a transaction that occurred on Monday, November 9th. The stock was sold at an average price of $433.85, for a total value of $2,384,005.75. Following the transaction, the insider directly owned 21,910 shares of the company’s stock, valued at $9,505,653.50. The trade was a 20.05% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.20% of the stock is currently owned by corporate insiders.

Humana News Summary

Here’s some of the latest news about HUM:

  • Positive Sentiment: Humana plans a National Gold Card program intended to reduce prior-authorization requirements for qualifying providers. It could ease administrative burdens, though the immediate financial impact is unclear. Humana launches National Gold Card Program
  • Neutral Sentiment: Humana expects some Louisville employees to return to the office starting in 2027; the change is not expected to be a major near-term financial driver. Humana to mandate office work for select Louisville staff
  • Negative Sentiment: CMS’s proposed CRUSH rule would expand anti-fraud oversight and strengthen Medicare Advantage risk-adjustment audits, including recovery of unsupported payments using plan-level extrapolation. CMS estimates roughly $9 billion in collections per payment year from the Medicare Advantage audit changes, within nearly $90 billion in projected savings across programs. Because Medicare Advantage is central to Humana’s business, investors may see the proposal as a risk of higher recoveries and compliance costs; the estimates are not Humana-specific. CMS CRUSH proposed rule

Wall Street Analyst Weigh In

Several research firms have commented on HUM. William Blair assumed coverage on Humana in a research report on Monday. They issued an “outperform” rating for the company. Evercore upgraded Humana from an “in-line” rating to an “outperform” rating and set a $480.00 price target on the stock in a report on Wednesday, July 29th. Leerink Partners raised Humana from a “market perform” rating to an “outperform” rating and set a $513.00 price objective for the company in a research note on Thursday, July 30th. ThinkEquity began coverage on shares of Humana in a report on Monday. They issued a “buy” rating for the company. Finally, Deutsche Bank began coverage on shares of Humana in a report on Thursday, July 30th. They issued a “hold” rating for the company. One research analyst has rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $484.78.

Read Our Latest Report on Humana

Humana Company Profile

(Free Report)

Humana Inc. is a U.S. health and wellness company that provides health insurance and healthcare services. Its insurance offerings include Medicare Advantage, Medicare Supplement and prescription drug plans, as well as Medicaid and employer-sponsored plans. The company also provides care through CenterWell, its healthcare services brand, which includes primary care, home health and pharmacy services. Its insurance and care offerings are available in markets across the United States, with availability varying by product and location.

See Also

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.